[1] |
Kundu BK,Naik AK,Bhargava S, et al. Diagnosing the SAPHO syndrome: a report of three cases and review of literature [J]. Clin Rheumatol, 2013, 32(8): 1237-1243.
|
[2] |
Perry A,Lambert P. Propionibacterium acnes: infection beyond the skin [J]. Expert Rev Anti Infect Ther, 2011, 9(12): 1149-1156.
|
[3] |
Przepierabdzak H,Fischer K,Brzosko M. Serum IL-6 and IL-23 levels and their correlation with angiogenic cytokines and disease activity in ankylosing spondylitis, psoriatic arthritis, and SAPHO syndrome [J]. Mediators Inflamm, 2015, 2015: 785705.
|
[4] |
Song X,Sun W,Meng Z, et al. Diagnosis and treatment of SAPHO syndrome: a case report [J]. Exp Ther Med, 2014, 8(2): 419 422.
|
[5] |
Nguyen MT,Borchers A,Selmi C, et al. The SAPHO syndrome [J]. Semin Arthritis Rheum, 2012, 42(3): 254-265.
|
[6] |
Depasquale R,Kumar N,Lalam RK, et al. SAPHO: what radiologists should know [J]. Clin Radiol, 2012, 67(3): 195-206.
|
[7] |
Heldmann F,Kiltz U,Baraliakos X, et al. SAPHO syndrome [J]. Zeitschrift Rheumatol, 2014, 73(8): 729-741.
|
[8] |
Hayem G. SAPHO syndrome [J]. Rev Prat, 2004,54(15): 1635-1636.
|
[9] |
Valentin R,Gürtler KF,Schaker A. Renal amyloidosis and renal failure-a novel complication of the SAPHO syndrome [J]. Nephrol Dial Transplant, 1997, 12(11): 2420-2423.
|
[10] |
Kakoki K,Miyata Y,Enokizono M, et al. Renal dysfunction due to hydronephrosis by SAPHO syndrome: a case report [J]. Clin Case Rep, 2015, 3(8): 686-689.
|
[11] |
Morimoto K,Nakatani K,Asai O, et al. A case of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome complicated by IgA nephropathy with nephrotic syndrome [J]. CEN Case Rep, 2016, 5(1): 26-30.
|
[12] |
Shiraishi W,Hayashi S,Iwanaga Y, et al. A case of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome presenting with hypertrophic achymeningitis [J].J Neurol Sci, 2015, 349(1-2): 229-231.
|
[13] |
Wu W,Debbaneh M,Moslehi H, et al. Tonsillectomy as a treatment for psoriasis: a review [J]. J Dermatolog Treat, 2014, 25(6): 482-486.
|
[14] |
Liu LL,Wang LN,Jiang Y, et al. Tonsillectomy for IgA nephropathy: a meta-analysis [J]. Am J Kidney Dis, 2015, 65(1): 80-87.
|
[15] |
Govoni M,Colina M,Massara A, et al. "SAPHO syndrome and infections" [J]. Autoimmun Rev, 2009, 8(3): 256-259.
|
[16] |
Hurtado-Nedelec M,Chollet-Martin S,Nicaise-Roland P, et al. Characterization of the immune response in the synovitis, acne, pustulosis, osteitis (SAPHO) syndrome [J]. Rheumatol(Oxford),2008, 47(8): 1160-1167.
|
[17] |
Firinu D,Murgia G,Lorrai MM, et al. Biological treatment for SAPHO syndrome: an update [J]. Inflamm Allergy Drug Targets, 2014, 13(3): 199-205.
|
[18] |
Rosenzwajg M,Languille E,Debiec H, et al. B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab [J]. Kidney Int, 2017, 92(1): 227-237.
|
[19] |
刘莉莉. Th17/Treg免疫平衡在特发性膜性肾病发病中的作用及环孢素A对其影响[D]. 北京协和医学院,2011.
|
[20] |
Jung J,Molinger M,Kohn D, et al. Intra-articular glucocorticosteroid injection into sternocostoclavicular joints in patients with SAPHO syndrome.[J]. Semin Arthritis Rheum, 2012, 42(3): 266-270.
|
[21] |
Kim CH,Kadhim S,Julien C. Treatment of pain in SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome [J]. PMR, 2014, 6(1): 92-95.
|
[22] |
Colina M,Trotta F. Clinical and radiological characteristics of SAPHO syndrome [J]. Curr Rheumatol Rev, 2013, 9(1): 22-27.
|
[23] |
Burgemeister LT,Baeten DL,Tas SW. Biologics for rare inflammatory diseases: TNF blockade in the SAPHO syndrome [J]. Neth J Med, 2012, 70(10): 444-449.
|